4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-17-001492
Options or other derivatives
- Director acquired 5,697 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Slager David Mark Director | 2017-02-09 | Grant or award · Stock Option (right to buy) | +5,697 | 5,697 | D | ||
Loading xslF345X03/f4020917slager_oramed.xml…